← Back to Search

Mobile 360° Video intervention for Type 2 Diabetes

N/A
Waitlist Available
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights

Study Summary

This study is evaluating whether a combination of text messages and videos may help motivate individuals with prediabetes to enroll in a diabetes prevention program.

Eligible Conditions
  • Type 2 Diabetes
  • Prediabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
4 weeks of engagement in the Diabetes prevention program
Diabetes prevention program enrollment
Secondary outcome measures
Changes in Risk perceptions
Changes in self-efficacy

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Motivation and Problem Solving (MAPS) armExperimental Treatment2 Interventions
After risk notification and education, participants will be called by a health coach trained in counseling/coaching. The coach will guide them in setting goals related to their health, and addressing any practical barriers to enrolling/engaging in the DPP if that is consistent with their health goals. Per their preference, participants will receive up to 5 phone calls from the health coach over a 4 week period.
Group II: Mobile 360° Video intervention armExperimental Treatment2 Interventions
After risk notification and education, participants will receive links to two 3-minute immersive Mobile 360° Videos (in which the viewer moves their phone to 'look around' the world of the video) on their smart phones. These videos are intended to influence affective and experiential perceptions of risk. The first video tells an emotional story of the negative effects on an individual's health and family life as they progress from prediabetes to T2DM and develop cardiovascular complications. The second video provides the viewer with a vicarious experience of the changes in vision that occur as diabetic retinopathy develops and worsens.
Group III: Risk notification/education armActive Control1 Intervention
We will send all participants a short message service (SMS) message with a link to a website that educates the public about their risk for developing T2DM and about the availability and efficacy of the DPP to address their risk
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mobile 360° Video intervention
2021
N/A
~820
Motivation and Problem Solving (MAPS)
2021
N/A
~820
Risk notification/education
2021
N/A
~820

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor
1,094 Previous Clinical Trials
1,774,699 Total Patients Enrolled
Centers for Disease Control and PreventionFED
875 Previous Clinical Trials
22,476,585 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
The Effect of 360 Video and MAPS on Enrollment in the DPP
Bryan Smith Gibson 2021. "The Effect of 360 Video and MAPS on Enrollment in the DPP". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04746781.
~196 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top